Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer
- PMID: 18309957
- DOI: 10.1200/JCO.2007.15.3304
Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer
Comment on
-
Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer.J Clin Oncol. 2007 Oct 20;25(30):4787-92. doi: 10.1200/JCO.2007.11.8521. J Clin Oncol. 2007. PMID: 17947726
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
